Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4)
0.1.0 - CI Build
Gravitate Health FHIR Implementation Guide (FHIR R4), published by . This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health-ips/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "gravitate-ips-jp",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Bundle-uv-ips"
]
},
"identifier" : {
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "ips-jp"
},
"type" : "document",
"timestamp" : "2021-09-03T08:38:00+02:00",
"entry" : [
{
"fullUrl" : "https://myserver.org/Composition/2fa5b223-ebce-4f39-9c66-5dc014f7359c",
"resource" : {
"resourceType" : "Composition",
"id" : "ips-example-2",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Composition-uv-ips"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Composition_ips-example-2\"> </a>\n \n\n \n <b>Id:</b>\n ips-example-2\n <br/>\n \n <b>status:</b>\n Final\n <br/>\n \n <b>Type:</b>\n Patient summary Document\n <br/>\n \n <b>Subject:</b>\n <a>IPS-JP</a>\n \n\n <br/>\n <b>Sections:</b>\n <br/>\n\n <ul>\n \n <li>\n\n Medication Summary\n\n </li>\n <ul>\n\n \n\n <li>\n\n Ogivri\ttrastuzumab 150 mg\tpowder for concentrate for solution for infusion\n\n </li>\n \n\n <li>\n\n Lipcut\tSimvastatin\t20 mg tablet\n\n </li>\n \n\n <li>\n\n Enbrel Etanercept 25 mg powder for solution for injection\n\n </li>\n \n\n <li>\n\n Tegretol Carbamazepine\t200 mg\ttablets\n\n </li>\n \n </ul>\n\n \n <li>\n\n Allergies and Intolerances\n\n </li>\n <ul>\n\n \n\n <li>\n\n No infos about Allergies\n\n </li>\n \n </ul>\n\n \n <li>\n\n Problem List\n\n </li>\n <ul>\n\n \n\n <li>\n\n Malignant neoplasm of breast (disorder)\n\n </li>\n \n\n <li>\n\n Hypercholesterolemia\n\n </li>\n \n\n <li>\n\n Rheumatoid arthritis\n\n </li>\n \n\n <li>\n\n Epilepsy (disorder)\n\n </li>\n \n </ul>\n\n \n\n </ul>\n\n \n\n</div>"
},
"status" : "final",
"type" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "60591-5",
"display" : "Patient summary Document"
}
]
},
"subject" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
},
"date" : "2018-07-10T15:22:00+02:00",
"author" : [
{
"reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d9c",
"display" : "Dr. JP"
}
],
"title" : "Patient Summary (IPSJP)",
"confidentiality" : "N",
"section" : [
{
"title" : "Medication Summary",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "10160-0",
"display" : "Hx of Medication use"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Ogivri\ttrastuzumab 150 mg\tpowder for concentrate for solution for infusion</li></ul><ul><li>Lipcut\tSimvastatin\t20 mg\ttablet</li></ul><ul><li>Enbrel Etanercept 25 mg powder for solution for injection</li></ul><ul><li>Tegretol Carbamazepine\t200 mg\ttablets</li></ul></div>"
},
"entry" : [
{
"reference" : "MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899c",
"display" : "Ogivri\ttrastuzumab 150 mg\tpowder for concentrate for solution for infusion"
},
{
"reference" : "MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78f9c",
"display" : "Lipcut\tSimvastatin\t20 mg tablet"
},
{
"reference" : "MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87b9c",
"display" : "Enbrel Etanercept 25 mg powder for solution for injection"
},
{
"reference" : "MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade94g9c",
"display" : "Tegretol Carbamazepine\t200 mg\ttablets"
}
]
},
{
"title" : "Allergies and Intolerances",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "48765-2",
"display" : "Allergies and adverse reactions Document"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>No infos about Allergies</li></ul></div>"
},
"entry" : [
{
"reference" : "AllergyIntolerance/0dff4474-fa08-4f45-8260-dbb23094bf09c",
"display" : "No infos about Allergies"
}
]
},
{
"title" : "Problem List",
"code" : {
"coding" : [
{
"system" : "http://loinc.org",
"code" : "11450-4",
"display" : "Problem list Reported"
}
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Malignant neoplasm of breast (disorder)</li></ul><ul><li>Hypercholesterolemia</li></ul><ul><li>Rheumatoid arthritis</li></ul><ul><li>Epilepsy</li></ul></div>"
},
"entry" : [
{
"reference" : "Condition/bcc79261-142c-48ec-b032-f3f9af49ec59c",
"display" : "Malignant neoplasm of breast (disorder)"
},
{
"reference" : "Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5139c",
"display" : "Hypercholesterolemia"
},
{
"reference" : "Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6259c",
"display" : "Rheumatoid arthritis"
},
{
"reference" : "Condition/f06b7cf8-c15c-4288-a0f9-45a1026e6789c",
"display" : "Epilepsy (disorder)"
}
]
}
]
}
},
{
"fullUrl" : "https://myserver.org/Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"resource" : {
"resourceType" : "Patient",
"id" : "c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Patient c154158f-6a43-4ab7-8443-e7f4bf915dd9c</b></p><a name=\"c154158f-6a43-4ab7-8443-e7f4bf915dd9c\"> </a><a name=\"hcc154158f-6a43-4ab7-8443-e7f4bf915dd9c\"> </a><a name=\"c154158f-6a43-4ab7-8443-e7f4bf915dd9c-en-US\"> </a><p style=\"border: 1px #661aff solid; background-color: #e6e6ff; padding: 10px;\">IPS-JP Gravitate Female, DoB: 1946-05-05 ( https://www.gravitatehealth.eu/sid/doc#ips-jp)</p><hr/><table class=\"grid\"><tr><td style=\"background-color: #f3f5da\" title=\"Record is active\">Active:</td><td colspan=\"3\">true</td></tr></table></div>"
},
"identifier" : [
{
"system" : "https://www.gravitatehealth.eu/sid/doc",
"value" : "ips-jp"
}
],
"active" : true,
"name" : [
{
"family" : "Gravitate",
"given" : [
"IPS-JP"
]
}
],
"gender" : "female",
"birthDate" : "1946-05-05"
}
},
{
"fullUrl" : "https://myserver.org/Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d9c",
"resource" : {
"resourceType" : "Practitioner",
"id" : "1ece89c5-fda3-4db9-ace6-decbe6c603d9c",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d9c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Practitioner 1ece89c5-fda3-4db9-ace6-decbe6c603d9c</b></p><a name=\"1ece89c5-fda3-4db9-ace6-decbe6c603d9c\"> </a><a name=\"hc1ece89c5-fda3-4db9-ace6-decbe6c603d9c\"> </a><a name=\"1ece89c5-fda3-4db9-ace6-decbe6c603d9c-en-US\"> </a><p><b>name</b>: IPS JP </p></div>"
},
"name" : [
{
"family" : "JP",
"given" : [
"IPS"
],
"prefix" : [
"Dr."
]
}
]
}
},
{
"fullUrl" : "https://myserver.org/AllergyIntolerance/0dff4474-fa08-4f45-8260-dbb23094bf09c",
"resource" : {
"resourceType" : "AllergyIntolerance",
"id" : "0dff4474-fa08-4f45-8260-dbb23094bf09c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/AllergyIntolerance-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"AllergyIntolerance_0dff4474-fa08-4f45-8260-dbb23094bf09c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: AllergyIntolerance 0dff4474-fa08-4f45-8260-dbb23094bf09c</b></p><a name=\"0dff4474-fa08-4f45-8260-dbb23094bf09c\"> </a><a name=\"hc0dff4474-fa08-4f45-8260-dbb23094bf09c\"> </a><a name=\"0dff4474-fa08-4f45-8260-dbb23094bf09c-en-US\"> </a><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical active}\">Active</span></p><p><b>verificationStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/allergyintolerance-verification confirmed}\">Confirmed</span></p><p><b>code</b>: <span title=\"Codes:{http://hl7.org/fhir/uv/ips/CodeSystem/absent-unknown-uv-ips no-allergy-info}\">no-allergy-info</span></p><p><b>patient</b>: <a href=\"Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\">IPS-JP</a></p></div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
"code" : "active"
}
]
},
"verificationStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
"code" : "confirmed"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://hl7.org/fhir/uv/ips/CodeSystem/absent-unknown-uv-ips",
"code" : "no-allergy-info"
}
]
},
"patient" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
}
}
},
{
"fullUrl" : "https://myserver.org/Condition/bcc79261-142c-48ec-b032-f3f9af49ec59c",
"resource" : {
"resourceType" : "Condition",
"id" : "bcc79261-142c-48ec-b032-f3f9af49ec59c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Condition_bcc79261-142c-48ec-b032-f3f9af49ec59c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Condition bcc79261-142c-48ec-b032-f3f9af49ec59c</b></p><a name=\"bcc79261-142c-48ec-b032-f3f9af49ec59c\"> </a><a name=\"hcbcc79261-142c-48ec-b032-f3f9af49ec59c\"> </a><a name=\"bcc79261-142c-48ec-b032-f3f9af49ec59c-en-US\"> </a><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}\">Active</span></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 254837009}\">Malignant neoplasm of breast</span></p><p><b>subject</b>: <a href=\"Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\">IPS-JP</a></p><p><b>asserter</b>: <a href=\"Bundle-gravitate-ips-jp.html#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d9c\">Dr. IPS-JP</a></p></div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
"code" : "active"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "254837009",
"display" : "Malignant neoplasm of breast (disorder)"
}
],
"text" : "Malignant neoplasm of breast"
},
"subject" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
},
"asserter" : {
"reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d9c",
"display" : "Dr. IPS-JP"
}
}
},
{
"fullUrl" : "https://myserver.org/Condition/a4a9d90a-d1b0-4d60-82f0-c52343dc6259c",
"resource" : {
"resourceType" : "Condition",
"id" : "a4a9d90a-d1b0-4d60-82f0-c52343dc6259c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Condition_a4a9d90a-d1b0-4d60-82f0-c52343dc6259c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Condition a4a9d90a-d1b0-4d60-82f0-c52343dc6259c</b></p><a name=\"a4a9d90a-d1b0-4d60-82f0-c52343dc6259c\"> </a><a name=\"hca4a9d90a-d1b0-4d60-82f0-c52343dc6259c\"> </a><a name=\"a4a9d90a-d1b0-4d60-82f0-c52343dc6259c-en-US\"> </a><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}\">Active</span></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 69896004}\">Rheumatoid arthritis</span></p><p><b>subject</b>: <a href=\"Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\">IPS-JP</a></p><p><b>onset</b>: 2015</p><p><b>asserter</b>: <a href=\"Bundle-gravitate-ips-jp.html#Practitioner_1ece89c5-fda3-4db9-ace6-decbe6c603d9c\">Dr. IPS-JP</a></p></div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
"code" : "active"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "69896004",
"display" : "Rheumatoid arthritis (disorder)"
}
],
"text" : "Rheumatoid arthritis"
},
"subject" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
},
"onsetDateTime" : "2015",
"asserter" : {
"reference" : "Practitioner/1ece89c5-fda3-4db9-ace6-decbe6c603d9c",
"display" : "Dr. IPS-JP"
}
}
},
{
"fullUrl" : "https://myserver.org/Condition/f06b7cf8-c15c-4288-a0f9-45a1026e5139c",
"resource" : {
"resourceType" : "Condition",
"id" : "f06b7cf8-c15c-4288-a0f9-45a1026e5139c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Condition_f06b7cf8-c15c-4288-a0f9-45a1026e5139c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Condition f06b7cf8-c15c-4288-a0f9-45a1026e5139c</b></p><a name=\"f06b7cf8-c15c-4288-a0f9-45a1026e5139c\"> </a><a name=\"hcf06b7cf8-c15c-4288-a0f9-45a1026e5139c\"> </a><a name=\"f06b7cf8-c15c-4288-a0f9-45a1026e5139c-en-US\"> </a><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}\">Active</span></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 13644009}\">Hypercholesterolemia</span></p><p><b>subject</b>: <a href=\"Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\">IPS-JP</a></p><p><b>onset</b>: 1993</p></div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
"code" : "active"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "13644009",
"display" : "Hypercholesterolemia (disorder)"
}
],
"text" : "Hypercholesterolemia"
},
"subject" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
},
"onsetDateTime" : "1993"
}
},
{
"fullUrl" : "https://myserver.org/Condition/f06b7cf8-c15c-4288-a0f9-45a1026e6789c",
"resource" : {
"resourceType" : "Condition",
"id" : "f06b7cf8-c15c-4288-a0f9-45a1026e6789c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Condition-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Condition_f06b7cf8-c15c-4288-a0f9-45a1026e6789c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Condition f06b7cf8-c15c-4288-a0f9-45a1026e6789c</b></p><a name=\"f06b7cf8-c15c-4288-a0f9-45a1026e6789c\"> </a><a name=\"hcf06b7cf8-c15c-4288-a0f9-45a1026e6789c\"> </a><a name=\"f06b7cf8-c15c-4288-a0f9-45a1026e6789c-en-US\"> </a><p><b>clinicalStatus</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}\">Active</span></p><p><b>code</b>: <span title=\"Codes:{http://snomed.info/sct 84757009}\">Epilepsy</span></p><p><b>subject</b>: <a href=\"Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\">IPS-JP</a></p><p><b>onset</b>: 1993</p></div>"
},
"clinicalStatus" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/condition-clinical",
"code" : "active"
}
]
},
"code" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "84757009",
"display" : "Epilepsy (disorder)"
}
],
"text" : "Epilepsy"
},
"subject" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
},
"onsetDateTime" : "1993"
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/29074ca4-efcb-4ff4-8446-feed2399a899c",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "29074ca4-efcb-4ff4-8446-feed2399a899c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_29074ca4-efcb-4ff4-8446-feed2399a899c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement 29074ca4-efcb-4ff4-8446-feed2399a899c</b></p><a name=\"29074ca4-efcb-4ff4-8446-feed2399a899c\"> </a><a name=\"hc29074ca4-efcb-4ff4-8446-feed2399a899c\"> </a><a name=\"29074ca4-efcb-4ff4-8446-feed2399a899c-en-US\"> </a><p><b>status</b>: Active</p><p><b>medication</b>: <a href=\"Bundle-gravitate-ips-jp.html#Medication_b50ae644-e0b7-4007-809f-26f493cbe369c\">trastuzumab</a></p><p><b>subject</b>: <a href=\"Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\">IPS-JP</a></p><p><b>effective</b>: 2015</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://standardterms.edqm.eu 20045000}\">Intravenous use</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/b50ae644-e0b7-4007-809f-26f493cbe369c",
"display" : "trastuzumab"
},
"subject" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
},
"effectiveDateTime" : "2015",
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20045000",
"display" : "Intravenous use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/f6cb1218-f81c-4338-80d8-3c10910f78f9c",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "f6cb1218-f81c-4338-80d8-3c10910f78f9c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_f6cb1218-f81c-4338-80d8-3c10910f78f9c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement f6cb1218-f81c-4338-80d8-3c10910f78f9c</b></p><a name=\"f6cb1218-f81c-4338-80d8-3c10910f78f9c\"> </a><a name=\"hcf6cb1218-f81c-4338-80d8-3c10910f78f9c\"> </a><a name=\"f6cb1218-f81c-4338-80d8-3c10910f78f9c-en-US\"> </a><p><b>status</b>: Active</p><p><b>medication</b>: <a href=\"Bundle-gravitate-ips-jp.html#Medication_de131e15-ed13-4b31-b38c-3204a84d99c9c\">simvastatin</a></p><p><b>subject</b>: <a href=\"Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\">IPS-JP</a></p><p><b>effective</b>: 2020</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://standardterms.edqm.eu 20053000}\">Oral use</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/de131e15-ed13-4b31-b38c-3204a84d99c9c",
"display" : "simvastatin"
},
"subject" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
},
"effectiveDateTime" : "2020",
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade87b9c",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "f26084c9-b1c8-46d9-acb2-1d400ade87b9c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_f26084c9-b1c8-46d9-acb2-1d400ade87b9c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement f26084c9-b1c8-46d9-acb2-1d400ade87b9c</b></p><a name=\"f26084c9-b1c8-46d9-acb2-1d400ade87b9c\"> </a><a name=\"hcf26084c9-b1c8-46d9-acb2-1d400ade87b9c\"> </a><a name=\"f26084c9-b1c8-46d9-acb2-1d400ade87b9c-en-US\"> </a><p><b>status</b>: Active</p><p><b>medication</b>: <a href=\"Bundle-gravitate-ips-jp.html#Medication_9ac3356c-4ea4-4814-84c3-235484f2ef19c\">enbrel</a></p><p><b>subject</b>: <a href=\"Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\">IPS-JP</a></p><p><b>effective</b>: 2023</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://standardterms.edqm.eu 20066000}\">Subcutaneous use</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/9ac3356c-4ea4-4814-84c3-235484f2ef19c",
"display" : "enbrel"
},
"subject" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
},
"effectiveDateTime" : "2023",
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20066000",
"display" : "Subcutaneous use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/MedicationStatement/f26084c9-b1c8-46d9-acb2-1d400ade94g9c",
"resource" : {
"resourceType" : "MedicationStatement",
"id" : "f26084c9-b1c8-46d9-acb2-1d400ade94g9c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/MedicationStatement-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicationStatement_f26084c9-b1c8-46d9-acb2-1d400ade94g9c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicationStatement f26084c9-b1c8-46d9-acb2-1d400ade94g9c</b></p><a name=\"f26084c9-b1c8-46d9-acb2-1d400ade94g9c\"> </a><a name=\"hcf26084c9-b1c8-46d9-acb2-1d400ade94g9c\"> </a><a name=\"f26084c9-b1c8-46d9-acb2-1d400ade94g9c-en-US\"> </a><p><b>status</b>: Active</p><p><b>medication</b>: <a href=\"Bundle-gravitate-ips-jp.html#Medication_9ac3356c-4ea4-4814-84c3-235484f2jk99c\">carbamazepine</a></p><p><b>subject</b>: <a href=\"Bundle-gravitate-ips-jp.html#Patient_c154158f-6a43-4ab7-8443-e7f4bf915dd9c\">IPS-JP</a></p><p><b>effective</b>: 2020</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://standardterms.edqm.eu 20053000}\">Oral use</span></td></tr></table></div>"
},
"status" : "active",
"medicationReference" : {
"reference" : "Medication/9ac3356c-4ea4-4814-84c3-235484f2jk99c",
"display" : "carbamazepine"
},
"subject" : {
"reference" : "Patient/c154158f-6a43-4ab7-8443-e7f4bf915dd9c",
"display" : "IPS-JP"
},
"effectiveDateTime" : "2020",
"dosage" : [
{
"route" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "20053000",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/b50ae644-e0b7-4007-809f-26f493cbe369c",
"resource" : {
"resourceType" : "Medication",
"id" : "b50ae644-e0b7-4007-809f-26f493cbe369c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_b50ae644-e0b7-4007-809f-26f493cbe369c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Medication b50ae644-e0b7-4007-809f-26f493cbe369c</b></p><a name=\"b50ae644-e0b7-4007-809f-26f493cbe369c\"> </a><a name=\"hcb50ae644-e0b7-4007-809f-26f493cbe369c\"> </a><a name=\"b50ae644-e0b7-4007-809f-26f493cbe369c-en-US\"> </a><p><b>code</b>: <span title=\"Codes:{http://iyaku.info/medicine/ 4291447D2024}\">4291447D2024</span></p><p><b>form</b>: <span title=\"Codes:{http://standardterms.edqm.eu 50042000}\">Powder and solvent for concentrate for solution for infusion</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://fdasis.nlm.nih.gov P188ANX8CK}\">trastuzumab</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "http://iyaku.info/medicine/",
"code" : "4291447D2024"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "50042000",
"display" : "Powder and solvent for concentrate for solution for infusion"
}
]
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "P188ANX8CK",
"display" : "trastuzumab"
}
],
"text" : "trastuzumab"
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/de131e15-ed13-4b31-b38c-3204a84d99c9c",
"resource" : {
"resourceType" : "Medication",
"id" : "de131e15-ed13-4b31-b38c-3204a84d99c9c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_de131e15-ed13-4b31-b38c-3204a84d99c9c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Medication de131e15-ed13-4b31-b38c-3204a84d99c9c</b></p><a name=\"de131e15-ed13-4b31-b38c-3204a84d99c9c\"> </a><a name=\"hcde131e15-ed13-4b31-b38c-3204a84d99c9c\"> </a><a name=\"de131e15-ed13-4b31-b38c-3204a84d99c9c-en-US\"> </a><p><b>code</b>: <span title=\"Codes:{http://iyaku.info/medicine/ 2189011F1262}, {https://www.who-umc.org/phpid F92168108C432D63DACDD70444176BB3}\">Lipcut\tSimvastatin\t5 mg\ttablet</span></p><p><b>form</b>: <span title=\"Codes:{http://standardterms.edqm.eu 10219000}\">Tablet</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://fdasis.nlm.nih.gov AGG2FN16EV}\">SIMVASTATIN</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "http://iyaku.info/medicine/",
"code" : "2189011F1262"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "F92168108C432D63DACDD70444176BB3",
"display" : "Lipcut\tSimvastatin\t5 mg\ttablet"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10219000",
"display" : "Tablet"
}
]
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "AGG2FN16EV",
"display" : "SIMVASTATIN"
}
],
"text" : "SIMVASTATIN"
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/9ac3356c-4ea4-4814-84c3-235484f2ef19c",
"resource" : {
"resourceType" : "Medication",
"id" : "9ac3356c-4ea4-4814-84c3-235484f2ef19c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_9ac3356c-4ea4-4814-84c3-235484f2ef19c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Medication 9ac3356c-4ea4-4814-84c3-235484f2ef19c</b></p><a name=\"9ac3356c-4ea4-4814-84c3-235484f2ef19c\"> </a><a name=\"hc9ac3356c-4ea4-4814-84c3-235484f2ef19c\"> </a><a name=\"9ac3356c-4ea4-4814-84c3-235484f2ef19c-en-US\"> </a><p><b>code</b>: <span title=\"Codes:{https://www.who-umc.org/phpid 0xF79CABF272B6A7EEF104DDDA44E82716}\">Enbrel Etanercept\t25 mg powder for solution for injection</span></p><p><b>form</b>: <span title=\"Codes:{http://standardterms.edqm.eu 50041500}\">Powder and solution for solution for injection</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://fdasis.nlm.nih.gov OP401G7OJC}\">Enbrel Etanercept\t25 mg</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "https://www.who-umc.org/phpid",
"code" : "0xF79CABF272B6A7EEF104DDDA44E82716",
"display" : "Enbrel Etanercept\t25 mg powder for solution for injection"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "50041500",
"display" : "Powder and solution for solution for injection"
}
],
"text" : "Powder and solution for solution for injection"
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "OP401G7OJC",
"display" : "ETANERCEPT (ENBREL)"
}
],
"text" : "Enbrel Etanercept\t25 mg"
}
}
]
}
},
{
"fullUrl" : "https://myserver.org/Medication/9ac3356c-4ea4-4814-84c3-235484f2jk99c",
"resource" : {
"resourceType" : "Medication",
"id" : "9ac3356c-4ea4-4814-84c3-235484f2jk99c",
"meta" : {
"profile" : [
🔗 "http://hl7.org/fhir/uv/ips/StructureDefinition/Medication-uv-ips"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Medication_9ac3356c-4ea4-4814-84c3-235484f2jk99c\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Medication 9ac3356c-4ea4-4814-84c3-235484f2jk99c</b></p><a name=\"9ac3356c-4ea4-4814-84c3-235484f2jk99c\"> </a><a name=\"hc9ac3356c-4ea4-4814-84c3-235484f2jk99c\"> </a><a name=\"9ac3356c-4ea4-4814-84c3-235484f2jk99c-en-US\"> </a><p><b>code</b>: <span title=\"Codes:{http://iyaku.info/medicine/ 1139002F1070}, {https://www.who-umc.org/phpid 5C62673C79E096D37914D32A45AA8F4D}, {https://www.who-umc.org/phpid FB9808F4FED210183F412F9998622287}\">Tegretol\tCarbamazepine\t200 mg\ttablets</span></p><p><b>form</b>: <span title=\"Codes:{http://standardterms.edqm.eu 10219000}\">Tablet</span></p><h3>Ingredients</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Item[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://fdasis.nlm.nih.gov 33CM23913M}\">CARBAMAZEPINE</span></td></tr></table></div>"
},
"code" : {
"coding" : [
{
"system" : "http://iyaku.info/medicine/",
"code" : "1139002F1070"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "5C62673C79E096D37914D32A45AA8F4D",
"display" : "Tegretol\tCarbamazepine\t200 mg\ttablets"
},
{
"system" : "https://www.who-umc.org/phpid",
"code" : "FB9808F4FED210183F412F9998622287",
"display" : "Tegretol\tCarbamazepine\t200 mg\ttablets"
}
]
},
"form" : {
"coding" : [
{
"system" : "http://standardterms.edqm.eu",
"code" : "10219000",
"display" : "Tablet"
}
]
},
"ingredient" : [
{
"itemCodeableConcept" : {
"coding" : [
{
"system" : "http://fdasis.nlm.nih.gov",
"code" : "33CM23913M",
"display" : "CARBAMAZEPINE"
}
],
"text" : "CARBAMAZEPINE"
}
}
]
}
}
]
}
IG © 2021+ . Package hl7.eu.fhir.gh-ips#0.1.0 based on FHIR 4.0.1. Generated 2024-10-01
Links: Table of Contents |
QA Report
The Gravitate Health project has received funding from the IMI 2 Joint Undertaking under grant agreement No 945334.
This joint undertaking receives support from the EU H2020 research and innovation programme and EFPIA.
